article thumbnail

Experts to come together for compliance event ‘validation ready’ global labeling systems  

pharmaphorum

Experts to come together for compliance event . exploring ‘validation ready’ global labeling systems . ? . A group of industry experts is set to explore how medical device, clinical trial and pharmaceutical companies can proactively manage labeling risk. Wokingham, United Kingdom —?27?April?2021?—

article thumbnail

Sentinel Events Should Result In A Blameless Society — Not Make The Employee The Scapegoat

The Happy PharmD

All events that jeopardized a patient’s safety, such as those involving falls, wrong surgical sites, clinical alarm mishaps, and other safety-related problems could result in a sentinel event. They were called sentinel events because of the immediate need for attention to address these errors. Every case was a sentinel event?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our 2024 Nursing Calculations Quiz

OctariusRx

The National Coordinating Council for Medication Error Reporting and Prevention defines medication error as any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient, or consumer. Need help making the conversion?

article thumbnail

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

pharmaphorum

When events moved online, societies and associations recognised the wider access afforded by “virtual”, and now, as the world slowly gets back on track, many have opted for a hybrid model that offers the best of both. Here, we take a look at the top five takeaways from the document: 1. Identifying the appropriate code and label.

article thumbnail

Our 2023 Nursing Calculations Quiz

OctariusRx

The National Coordinating Council for Medication Error Reporting and Prevention defines medication error as any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient, or consumer. Need help making the conversion?

article thumbnail

FDA adcomm votes down Cytokinetics heart failure drug

pharmaphorum

.” The experts reviewed data from the GALACTIC-HF trial, conducted when Cytokinetics was partnering the drug with Amgen, in which the drug met its primary objective of reducing cardiovascular death or heart failure events compared with placebo in HFrEF patients, cutting the combined rate by 8%. with omecamtiv mecarbil from 39.1%

FDA 52
article thumbnail

FDA’s New Draft Guidance on 510(k) Implant Devices: What You Need to Know

The FDA Law Blog

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”